|
Category:
|
7TM Receptors Peptides (Cardiovascular) Bradykinin Receptors
|
|
Cat.No.
|
Product Name
|
|
3014 |
HOE 140
|
| Alternative name(s): |
Icatibant |
|
|
Price and Availability
Click here for full price details of
HOE 140
|
|
|
|
|
Biological Activity:
Potent and selective bradykinin B2
receptor antagonist (pA2 = 9.04). Also inhibits aminopeptidase N (Ki
= 9.1 μM).
|
Technical Data:
|
|
|
Resources:
|
|
Certificate of Analysis / MSDS:
|
References:
Hock et al
(1991) Hoe 140 a new potent and long acting bradykinin-antagonist: in vitro
studies. Br.J.Pharmacol. 102 769. Feletou et al
(1994) Agonistic and antagonistic properties of the bradykinin B2
receptor antagonist, Hoe 140, in isolated blood vessels from different species.
Br.J.Pharmacol. 112 683. Bawolak et al (2006) The
bradykinin B2 receptor antagonist icatibant (Hoe 140) blocks
aminopeptidase N at micromolar concentrations: off-target alterations of
signaling mediated by the bradykinin B1 and angiotensin receptors.
Eur.J.Pharmacol. 551 108.
|
|
View related products by Pharmacological Action
or by Research Area
Keywords: HOE 140, Peptides (Cardiovascular), Potent & Selective B2 Antagonist, Icatibant, HOE140, Tocris Bioscience
|
|
|